\r\nIt is a great pleasure working with a team with the level of dedication and professionalism necessary to meet the requirements of this accreditation award.\u201d\u2014 Tom Fulmer, VP Business Development<\/p>\r\n<\/blockquote>\r\n\r\n\r\n\r\n
The Drug and Alcohol Testing Industry Association (DATIA) was founded in 1995 and has grown to represent over 1500 member companies, and expanded its scope. DATIA now represents the entire spectrum of drug and alcohol service providers including collection sites, laboratories, consortiums\/TPAs, MROs, and testing equipment manufacturers.<\/p>\r\n\r\n\r\n\r\n
National Drug Screening (NDS) provides drug testing services in all areas of the United States to small and medium size businesses. NDS offers one system for scheduling, ordering and processing paperless drug testing (both DOT and nonDOT) using all major SAMHSA laboratories as well as Medical Review Officer Services (MRO). Clients save time and money with an efficient electronic process for ordering tests and receiving test results. NDS also provides point of collection testing (POCT) programs that provide for negative drug test result to be electronically delivered to the client within minutes.<\/p>\r\n\r\n\r\n\r\n
Tom Fulmer
National Drug Screening, Inc.
3216222040
email us here<\/p>\r\n\r\n\r\n\r\n
Discover the Difference with National Drug Screening<\/p>\r\n","protected":false},"excerpt":{"rendered":"
MELBOURNE, FLORIDA, UNITED STATES, August 9, 2018 — National Drug Screening (Melbourne, FL) has again received national recognition as an administrator of drug and alcohol testing programs commonly called a third party administrator or TPA. The accreditation program is provided by the Drug and Alcohol Testing Industry Association (DATIA – DATIA merged with NDASA\u00a0in 2023). […]<\/p>\n","protected":false},"author":2,"featured_media":1138,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[45],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/55001"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=55001"}],"version-history":[{"count":2,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/55001\/revisions"}],"predecessor-version":[{"id":118387,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/55001\/revisions\/118387"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/1138"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=55001"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=55001"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=55001"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}